The Clinical Guidelines Program is a longstanding, collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases.
Mission: To develop and disseminate practical, evidence-based clinical guidelines that promote quality medical care for people in New York who are living with and/or are at risk of acquiring HIV, HCV, STIs and substance use.
Expert committees: AIDS Institute clinical guidelines are developed by committees of expert New York State clinicians. Committee members collaborate to survey and evaluate peer-reviewed literature, write and assess clinical recommendations, and update existing guidelines or create new guidelines as necessary to ensure that recommendations reflect current best practices. All new and revised guidelines undergo peer and consumer review.
Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.
Audience: AIDS Institute clinical care guidelines are produced and disseminated to clinicians in New York who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs and substance use.
Stay Up-To-Date with the Clinical Guidelines Program: Subscribe to Topics, Trends & Updates to receive an email announcement when new guidelines or updates to guidelines are published, along with highlights from hot topics and events, and trends in guideline use. Subscribe now
Let Us Know What You Think: Complete our brief survey to give feedback on the guidelines and the website. Complete the survey now
- Topics, Trends & Updates (1/7/21)
- Guidance: Adolescent Consent to HIV and STI Treatment and Prevention (1/6/21)
- New Guideline: Substance Use Screening and Risk Assessment in Adults (10/21/20)
- Diagnosis and Management of HIV-2 in Adults Updated (10/5/20)
- Updated PEP Guideline Recommendations for Managing a Potential HCV Exposure (10/2/20)
- New Guidance: Screening, Diagnosis, and Treatment of Mycoplasma genitalium (9/28/20)
- Medscape Commentary: Growing Old With HIV: Beyond Just Surviving (9/17/20)
- Updated: Diagnosis and Management of Acute HIV (8/26/2020)
- Medical Care Criteria Committee Advocates COVID-19 Vaccine Priority Status for People With HIV (1/12/21)
- Guidance: Opioid Use Disorder Treatment During COVID-19 (1/4/21)
- Guidance: Strategies for STI Screening and Treatment During COVID-19 (11/5/2020)
- Guidance: Rapid ART Initiation During COVID-19 (8/26/20)
- CEI Newsletter (1/12/21)
- CEI Podcast: Any Positive Change: A Drug User Health Podcast (1/12/21)
- NYS Medicaid Update: December 2020 (1/8/21)
- NYCDOHMH: Summary of Guidance and Resources from City Health Information 2020 (1/1/21)
- Clinicalinfo: Updated HHS Perinatal Antiretroviral Treatment Guidelines Released (12/29/20)
- Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020 (12/20/20)
- Medical Care Criteria Committee Advocates COVID-19 Vaccine Priority Status for People With HIV (1/12/21)
- NYCDOHMH: Dear Colleague Clinical considerations for Moderna COVID-19 vaccine (12/28/20)
- NYCDOHMH: Dear Colleague Allocation of Limited COVID-19 Vaccine (12/24/20)
- NYCDOHMH: Dear Colleague Clinical considerations for Pfizer-BioNtech COVID-19 vaccine (12/17/20)
- NYC DOHMH: Dear Colleague COVID-19 Updates, Long-Term Sequelae of COVID-19 (12/5/20)
- NYSDOH: Find a COVID-19 Test Site Near You (10/14/20)